HIF1A and cancer: Cancer cell-derived EVs carry key angiogenic factors, such as vascular endothelial growth factor, fibroblast growth factor, and hypoxia-inducible factor-1α (HIF-1α), which enhance endothelial cell proliferation and migration, leading to the formation of new blood vessels (6).